A patient developed Candida albicans endocarditis and fungemia after undergoing aortic valve replacement with an allograft. The allograft had been found during tissue bank processing to be contaminated with C. albicans, but it was culture-negative for C. albicans after routine disinfection with an antifungal-containing antimicrobial solution. Comparison of the preimplantation and postimplantation C. albicans isolates revealed remarkable genetic similarity, but antifungal susceptibility testing showed that the postimplantation isolate was more resistant to fluconazole and amphotericin B than the preimplantation isolate, suggesting emergence of resistance after disinfection. Implantation of a contaminated heart valve allograft can occur despite disinfection during processing and can result in endocarditis in the recipient. Antimicrobial disinfection protocols that include antifungal drugs may be ineffective. Current U.S. Food and Drug Administration regulations do not require companies to specify details concerning allograft processing. Additional measures may be required to prevent tissue bank release of allografts contaminated with C. albicans or other pathogens.
Since the first aortic valve allograft replacement was deCase Report scribed in 1962, the clinical use of allografts has been limited A 61-year-old man underwent allograft aortic valve (Cryoby their supply and durability [1] . Efforts to increase the supply life, Marietta, GA) replacement for long-standing aortic insufof usable valve allografts have resulted in the development of ficiency. There were no immediate postoperative complicanew methods of valve collection, disinfection, and cryopresertions, and the patient was discharged 5 days later. Sixteen vation that have been associated with varying rates of allograft days after surgery, the patient was readmitted because of fever contamination [2] .
(temperature, 104ЊF), nausea, and diarrhea. A physical examination revealed abdominal tenderness. The patient's WBC See editorial response by Joly and Carbon on pages 692-4. count was 6,800/mm 3 . Cultures of blood drawn on admission were positive for Candida albicans, and therapy with intravenous amphotericin B (Bristol-Myers Squibb, Princeton, NJ) and Contamination of a valve allograft can lead to endocarditis oral flucytosine (Hoffmann-LaRoche, Nutley, NJ) was started. in the recipient, an especially serious and often fatal condition Fungal endocarditis was suspected, and transesophageal [3] . Fungal endocarditis, although more unusual than bacterial echocardiography revealed aortic valve allograft dehiscence; endocarditis, is associated with a particularly high mortality the patient underwent replacement of the infected aortic valve rate. In this article, we describe the development of fungal allograft with another allograft from the same supplier. Intraopendocarditis associated with the implantation of a contaminated erative examination confirmed dehiscence of the aortic valve aortic valve allograft.
from the septum; in addition, an intramyocardial abscess and multiple vegetations were found in and around the suture line. Photomicroscopic examination of smears of a swab specimen of the valve surface prepared with potassium hydroxide (KOH)
Methods
All C. albicans isolates were identified by routine methods. Antifungal susceptibility testing by broth macrodilution was performed by the authors according to the methods of the National Committee for Clinical Laboratory Standards [4] . Pulsed-field gel electrophoresis and gene probe with use of the Ca3 probe were performed as previously described [5] .
Isolate genotyping and antifungal susceptibility testing. The C. albicans isolates obtained from valve tissue during processing and at the time of removal of the valve from the recipient were highly similar according to DNA fingerprinting using Southern blot hybridization with the DNA probe Ca3 [5, 6] (figure 1). The two isolates differed by a single, highmolecular-weight band, which represents a hypervariable segment that hybridizes with the C1 sequence of the Ca3 probe [5, 7] . A dendrogram in which the two isolates were compared with 20 isolates randomly chosen from the Dendron database [6] demonstrates their high degree of relatedness (figure 2).
Antifungal susceptibility testing revealed that the isolate obtained from the valve post-implantation was more resistant to fluconazole and amphotericin B than was the isolate obtained during allograft processing (table 1). The two isolates showed equivalent susceptibility to flucytosine, ketoconazole (Janssen Pharmaceutica, Titusville, NJ), and itraconazole (Janssen Pharmaceutica).
Discussion
The allograft heart valve is harvested from a brain-dead or postmortem donor, processed in an antimicrobial disinfection solution, cryopreserved, and stored until the valve is requested for implantation. Tissue samples obtained for sterility testing are cultured for bacteria, fungi, and acid-fast bacilli at multiple stages during harvesting and processing to rule out microbial contamination of the valve. Tissue samples are obtained by trimming of the valve at harvesting, and the valve ''trimmings'' are cultured before and after antimicrobial disinfection [8] . Sources of contamination of a valve allograft include the donor, the environment during harvesting and processing, and the operating room during implantation [9] . Subsequently, the harvested valve was soaked in an antimicroFungal endocarditis secondary to extrinsic valve contaminabial solution containing amphotericin B, fluconazole (Pfizer, tion is a rare but potentially fatal complication of allograft New York), imipenem (Merck & Co., West Point, PA), netilvalve replacement. The incidence of fungal endocarditis that micin (Schering-Plough, Kenilworth, NJ), and vancomycin (Eli occurs following surgery for heart valve replacement with alloLilly & Co., Indianapolis). After disinfection a sample of the valve was recultured, and no fungal growth was evident.
grafts is estimated at 0.3% -1.4% [2, 10, 11] . For many of these / 9C57$$oc24 09-15-98 16:11:58 cidas UC: CID were discarded because of contamination, but a minority of contaminating organisms were fungal (6 of 642) [2] . Disinfection of valve allografts through the use of various antimicrobial combinations was first described in the late 1960s [13, 14] . Since that time, antimicrobial agents used for disinfection have been further modified to improve efficacy and valve viability, increasing the supply of usable allografts [2, 12] . However, antifungal agents used for disinfection may damage allograft valve tissue and also may be ineffective. Reports of rates of fungal contamination following disinfection vary widely (1.7% -28.0%), and data indicate that inclusion of antifungal drugs in the disinfection regimen is not effective in eradicating fungal contamination [2, 10] . In some centers, antifungal agents have been removed from the disinfection protocol because of these concerns.
Five tissue banks supply the majority of heart valve allografts in the United States. Four organizations are grouped under an accrediting organization, the American Association of Tissue Banks (AATB), which requires that tissue banks disinfect tissues via a time-specific antibiotic incubation and that facilities establish, validate, and document antibiotic regimens and microbial surveillance methods [15] . AATB-affiliated organizations follow a similar disinfection protocol, using a solution In contrast, at Cryolife, a tissue bank that reportedly provides ú85% of cryopreserved heart valve allografts in the United be ascertained by the authors.
In the episode described in this article, genetic analyses confirmed that the C. albicans isolate obtained from the valve before disinfection was nearly identical to the isolate obtained reported cases, the source of contamination was not identified. Treatment is often unsuccessful, and death is frequently the postimplantation. Isolate exposure to the antifungal drugs used during valve disinfection may have resulted in the emergence of outcome. In one review, ú40% (11 of 27) of patients who acquired fungal endocarditis after valve allograft implantation a more-resistant strain, accounting for the decreased antifungal died within 2 weeks of diagnosis [11] .
Varying contamination rates measured during allograft heart 
